Li, X, Bilcke, J, van der Velden, A W, Bruyndonckx, R, Coenen, S, Bongard, E, de Paor, M, Chlabicz, S, Godycki-Cwirko, M, Francis, N, Aabenhus, R, Bucher, H C, Colliers, A, De Sutter, A, Garcia-Sangenis, A, Glinz, D, Harbin, N J, Kosiek, K, Lindbaek, M, Lionis, C, Llor, C, Miko-Pauer, R, Jurgute, R R, Seifert, B, Sundvall, P-D, Lundgren, P T, Tsakountakis, N, Verheij, T J, Goossens, H, Butler, C C, Beutels, P & ALIC4Etrial Investigators 2023, ' Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness : economic evaluation alongside the randomised controlled ALIC 4 E trial in 15 European countries ', European Journal of Health Economics, vol. 24 . https://doi.org/10.1007/s10198-022-01521-2 The European journal of health economics